European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC): Lung cancer.

Audit Cancer centre Cancer unit Care pathways Essential requirements Europe Guidelines Health inequalities Healthcare system Lung cancer Multidisciplinary Multidisciplinary team Organisation of care Patient information Patient-centred Quality Quality assurance

Journal

Lung cancer (Amsterdam, Netherlands)
ISSN: 1872-8332
Titre abrégé: Lung Cancer
Pays: Ireland
ID NLM: 8800805

Informations de publication

Date de publication:
12 2020
Historique:
received: 24 08 2020
accepted: 26 08 2020
pubmed: 24 11 2020
medline: 22 6 2021
entrez: 23 11 2020
Statut: ppublish

Résumé

European Cancer Organisation Essential Requirements for Quality Cancer Care (ERQCC) are written by experts representing all disciplines involved in cancer care in Europe. They give patients, health professionals, managers and policymakers a guide to essential care throughout the patient journey. Lung cancer is the leading cause of cancer mortality and has a wide variation in treatment and outcomes in Europe. It is a major healthcare burden and has complex diagnosis and treatment challenges. Care must only be carried out in lung cancer units or centres that have a core multidisciplinary team (MDT) and an extended team of health professionals detailed here. Such units are far from universal in European countries. To meet European aspirations for comprehensive cancer control, healthcare organisations must consider the requirements in this paper, paying particular attention to multidisciplinarity and patient-centred pathways from diagnosis, to treatment, to survivorship.

Identifiants

pubmed: 33227525
pii: S0169-5002(20)30591-2
doi: 10.1016/j.lungcan.2020.08.017
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

221-239

Informations de copyright

Copyright © 2020. Published by Elsevier B.V.

Auteurs

Thierry Berghmans (T)

European Organisation for Research and Treatment of Cancer (EORTC); Thoracic Oncology Clinic, Institut Jules Bordet, Brussels, Belgium.

Yolande Lievens (Y)

European Society for Radiotherapy and Oncology (ESTRO); Radiation Oncology Department, Ghent University Hospital, Belgium.

Matti Aapro (M)

European Cancer Organisation; Genolier Cancer Center, Genolier, Switzerland.

Anne-Marie Baird (AM)

European Cancer Organisation Patient Advisory Committee; Central Pathology Laboratory, St James's Hospital, Dublin, Ireland.

Marc Beishon (M)

Cancer World, European School of Oncology (ESO), Milan, Italy. Electronic address: marcbeishon@icloud.com.

Fiorella Calabrese (F)

European Society of Pathology (ESP); Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padova Medical School, Padova, Italy.

Csaba Dégi (C)

International Psycho-Oncology Society (IPOS); Faculty of Sociology and Social Work, Babes-Bolyai University, Cluj-Napoca, Romania.

Roberto C Delgado Bolton (RC)

European Association of Nuclear Medicine (EANM); Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, San Pedro Hospital and Centre for Biomedical Research of La Rioja (CIBIR); University of La Rioja, Logroño, La Rioja, Spain.

Mina Gaga (M)

European Respiratory Society (ERS); 7th Respiratory Medicine Department, Athens Chest Hospital Sotiria, Athens, Greece.

József Lövey (J)

Organisation of European Cancer Institutes (OECI); National Institute of Oncology, Budapest, Hungary.

Andrea Luciani (A)

International Society of Geriatric Oncology (SIOG); Medical Oncology, Ospedale S. Paolo, Milan, Italy.

Philippe Pereira (P)

Cardiovascular and Interventional Radiological Society of Europe (CIRSE); Clinic for Radiology, Minimally-Invasive Therapies and Nuclear Medicine, SLK-Kliniken, Heilbronn, Germany.

Helmut Prosch (H)

European Society of Radiology (ESR); Department of Biomedical Imaging and Image-guided Therapy, Medical University of Vienna, Austria.

Marika Saar (M)

European Society of Oncology Pharmacy (ESOP); Tartu University Hospital, Tartu, Estonia.

Michael Shackcloth (M)

European Society of Surgical Oncology (ESSO); Department of Thoracic Surgery, Liverpool Heart and Chest Hospital, Liverpool, United Kingdom.

Geertje Tabak-Houwaard (G)

European Oncology Nursing Society (EONS); Deventer Hospital, Deventer, Netherlands.

Alberto Costa (A)

European School of Oncology (ESO), Milan, Italy.

Philip Poortmans (P)

European Cancer Organisation; Iridium Kankernetwerk and University of Antwerp, Wilrijk-Antwerp, Belgium.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH